search
Back to results

Respiratory Muscles and Work of Breathing in Children (WOB&MR_Ped)

Primary Purpose

Neuromuscular Diseases, Congenital Diaphragmatic Hernia, Lung Diseases

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Esogastric pressure measurement
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Neuromuscular Diseases focused on measuring Respiratory muscle testing, Respiratory muscle strength, Work of breathing, Esogastric pressures, Diaphragmatic dysfunction, Diaphragmatic paralysis

Eligibility Criteria

0 Years - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients aged less than 18 years old with primary or secondary impairment of respiratory muscles and followed at Necker Hospital
  • Patients under spontaneous breathing or noninvasive or invasive mechanical ventilation
  • Written informed consent

Exclusion Criteria:

  • No social insurance
  • Significant psychomotor retardation
  • Absence of cooperation
  • Significant agitation
  • Hemodynamic instability
  • Acute condition or temporary drug treatments that may interfere with the results of the respiratory muscle explorations

Sites / Locations

  • Hôpital Necker-Enfants MaladesRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Respiratory muscle impairment

Arm Description

Minor patients with primary or secondary impairment of respiratory muscles and followed at Necker Hospital

Outcomes

Primary Outcome Measures

Esophageal pressure-time product (PTPoes)
The integral of the esophageal pressure signal over inspiratory time
Diaphragmatic pressure-time product (PTPdi)
The integral of the transdiaphragmatic pressure signal over inspiratory time
Work of breathing (WOB)
Total work of breathing (WOBt) is calculated (in Joules/L) as the area under the pressure-volume curve, using the Campbell diagram. Elastic (WOBe) and resistive (WOBr) are estimated as the 2/3 and 1/3 of WOBt value, respectively.

Secondary Outcome Measures

Vital capacity
Vital capacity is the maximum amount of air a person can expel from the lungs after a maximum inhalation, using spirometry
Maximal respiratory static pressures
Maximal static inspiratory and expiratory airway pressures
Maximal sniff pressure
Airway pressure during a sniff test
Maximal whistle pressure
Airway pressure during a whistle test
Peak expiratory flow
Maximal flow during expiratory maneuver
Peak cough flow
Maximal flow during cough
Esophageal pressure during sniff
Esophageal pressure measurement during a sniff test
Gastric pressure during sniff
Gastric pressure measurement during a sniff test
Transdiaphragmatic pressure during sniff
Transdiaphragmatic pressure measurement during a sniff test
Crying transdiaphragmatic pressure
Transdiaphragmatic pressure measurement during crying in young children
Gastric pressure during cough
Gastric pressure measurement during a maximal cough maneuver
Twitch transdiaphragmatic pressure
Transdiaphragmatic pressure measurement during cervical magnetic stimulation
Inspiratory muscles tension-time index
Measurement of the tension-time index of the inspiratory muscles
Diaphragmatic tension-time index
Measurement of the tension-time index of the diaphragm
Correlation between the pressure-time product, the work of breathing and the respiratory muscle strength with the disease severity
The pressure-time product of the respiratory muscles, the work of breathing and the respiratory muscle strength will be correlated with disease severity
Correlation between the pressure-time product, the work of breathing and the respiratory muscle strength with polysomnography and gas exchange results
The pressure-time product of the respiratory muscles, the work of breathing and the respiratory muscle strength will be correlated with the polysomnography and gas exchange results
Esophageal pressure-time products in patients with any treatment and in patients with no treatment
The esophageal pressure-time product will be compared between patients with any treatment and patients receiving no treatment
The total work of breathing in patients with any treatment and in patients with no treatment
The total work of breathing (WOBt), which is calculated (in Joules/L) as the area under the pressure-volume curve using the Campbell diagram, be compared between patients with any treatment and patients receiving no traeatment, using the Student t test
Measurement of esophageal pressure during a sniff in patients with any treatment and patients with no treatment
The esophageal pressure during a sniff will be compared between patients with any treatment and patients receiving no treatment
Measurement of the esophageal pressure-time product before and after pharmacological treatment
The esophageal pressure-time product will be compared before treatment, and 6 months and 1 year after pharmacological treatment initiation
The total work of breathing before and after pharmacological treatment
The total work of breathing (WOBt), which is calculated (in Joules/L) as the area under the pressure-volume curve using the Campbell diagram, will be compared before treatment, and 6 months and 1 year after pharmacological treatment initiation, using the ANOVA on repeated measures
Measurement of the esophageal pressure during a sniff before and after pharmacological treatment
The esophageal pressure during a sniff will be compared before treatment, and 6 months and 1 year after pharmacological treatment initiation
Measurement of transdiaphragmatic pressure during a sniff before and after pharmacological treatment
The transdiaphragmatic pressure measurement during a sniff will be compared before treatment, and 6 months and 1 year after pharmacological treatment initiation
Adaptation of the respiratory support according to the esophageal pressure-time product values
The esophageal pressure-time product will be measured to guide the respiratory support adaptation
Adaptation of the respiratory support according to the total work of breathing values
The total work of breathing (WOBt), which is calculated (in Joules/L) as the area under the pressure-volume curve using the Campbell diagram, will be measured to guide the respiratory support adaptation
Measurement of the esophageal pressure-time product in patients with weaning success and in patients with weaning failure
The esophageal pressure-time product will be compared between patients with weaning success and weaning failure
Measurement of the total work of breathing in patients with weaning success and in patients with weaning failure
The total work of breathing (WOBt), which is calculated (in Joules/L) as the area under the pressure-volume curve using the Campbell diagram, will be compared between patients with weaning success and weaning failure, using the Student t test
Measurement of the esophageal pressure during a sniff in patients with weaning success and in patients with weaning failure
The esophageal pressure during a sniff will be compared between patients with weaning success and weaning failure
Correlation between the pressure-time product, the work of breathing and the respiratory muscle strength with the gas exchange during weaning trial
The pressure-time product, the work of breathing and the respiratory muscle strength will be correlated with the gas exchange during a weaning trial

Full Information

First Posted
June 14, 2021
Last Updated
March 4, 2022
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT05051254
Brief Title
Respiratory Muscles and Work of Breathing in Children
Acronym
WOB&MR_Ped
Official Title
Respiratory Muscles and Work of Breathing in Children
Study Type
Interventional

2. Study Status

Record Verification Date
February 2022
Overall Recruitment Status
Recruiting
Study Start Date
January 19, 2022 (Actual)
Primary Completion Date
January 2028 (Anticipated)
Study Completion Date
January 2028 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Respiratory muscle testing allows a quantitative assessment of inspiratory and expiratory muscles in children of any age with primary or secondary respiratory muscle impairment, in order to better understand the pathophysiology of respiratory impairment and guide therapeutic management. The use of an invasive technique (esogastric probe) makes it possible to specifically explore the diaphragm, the accessory inspiratory muscles and the expiratory muscles in order to detect dysfunction or paralysis of these muscles, and to estimate the work of breathing in order to better guide the respiratory management. The primary objective of the study is to evaluate the respiratory effort in children with primary or secondary impairment of the respiratory muscles during spontaneous breathing or during mechanical ventilation.
Detailed Description
Respiratory muscle testing allows a quantitative assessment of inspiratory and expiratory muscles in children of any age with primary or secondary respiratory muscle impairment, in order to better understand the pathophysiology of respiratory impairment and guide therapeutic management. The use of an invasive technique (esogastric probe) makes it possible to specifically explore the diaphragm, the accessory inspiratory muscles and the expiratory muscles in order to detect dysfunction or paralysis of these muscles, and to estimate the work of breathing in order to better guide the respiratory management. Respiratory muscle testing by means of esogastric measurements may allow assessing the effect of pharmacological treatment by comparing respiratory muscle strength before and after a few months with treatment. Moreover, esogastric measurements can be used to better adapt mechanical ventilation or to determine the possibility of weaning from the respiratory support. The primary objective of the study is to evaluate the respiratory effort in children with primary or secondary impairment of the respiratory muscles during spontaneous breathing or during mechanical ventilation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neuromuscular Diseases, Congenital Diaphragmatic Hernia, Lung Diseases, Cardiac Diseases, Scoliosis, Diaphragmatic Impairment, Respiratory Muscle Impairment
Keywords
Respiratory muscle testing, Respiratory muscle strength, Work of breathing, Esogastric pressures, Diaphragmatic dysfunction, Diaphragmatic paralysis

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
550 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Respiratory muscle impairment
Arm Type
Experimental
Arm Description
Minor patients with primary or secondary impairment of respiratory muscles and followed at Necker Hospital
Intervention Type
Other
Intervention Name(s)
Esogastric pressure measurement
Intervention Description
Measurement of work of breathing and respiratory muscles strength using an esogastric catheter. One measurement or before and after (6 months and 1 year) the initiation of a pharmacological treatment in order to assess the effect of the treatment on respiratory muscle function.
Primary Outcome Measure Information:
Title
Esophageal pressure-time product (PTPoes)
Description
The integral of the esophageal pressure signal over inspiratory time
Time Frame
Day 0
Title
Diaphragmatic pressure-time product (PTPdi)
Description
The integral of the transdiaphragmatic pressure signal over inspiratory time
Time Frame
Day 0
Title
Work of breathing (WOB)
Description
Total work of breathing (WOBt) is calculated (in Joules/L) as the area under the pressure-volume curve, using the Campbell diagram. Elastic (WOBe) and resistive (WOBr) are estimated as the 2/3 and 1/3 of WOBt value, respectively.
Time Frame
Day 0
Secondary Outcome Measure Information:
Title
Vital capacity
Description
Vital capacity is the maximum amount of air a person can expel from the lungs after a maximum inhalation, using spirometry
Time Frame
Day 0
Title
Maximal respiratory static pressures
Description
Maximal static inspiratory and expiratory airway pressures
Time Frame
Day 0
Title
Maximal sniff pressure
Description
Airway pressure during a sniff test
Time Frame
Day 0
Title
Maximal whistle pressure
Description
Airway pressure during a whistle test
Time Frame
Day 0
Title
Peak expiratory flow
Description
Maximal flow during expiratory maneuver
Time Frame
Day 0
Title
Peak cough flow
Description
Maximal flow during cough
Time Frame
Day 0
Title
Esophageal pressure during sniff
Description
Esophageal pressure measurement during a sniff test
Time Frame
Day 0
Title
Gastric pressure during sniff
Description
Gastric pressure measurement during a sniff test
Time Frame
Day 0
Title
Transdiaphragmatic pressure during sniff
Description
Transdiaphragmatic pressure measurement during a sniff test
Time Frame
Day 0
Title
Crying transdiaphragmatic pressure
Description
Transdiaphragmatic pressure measurement during crying in young children
Time Frame
Day 0
Title
Gastric pressure during cough
Description
Gastric pressure measurement during a maximal cough maneuver
Time Frame
Day 0
Title
Twitch transdiaphragmatic pressure
Description
Transdiaphragmatic pressure measurement during cervical magnetic stimulation
Time Frame
Day 0
Title
Inspiratory muscles tension-time index
Description
Measurement of the tension-time index of the inspiratory muscles
Time Frame
Day 0
Title
Diaphragmatic tension-time index
Description
Measurement of the tension-time index of the diaphragm
Time Frame
Day 0
Title
Correlation between the pressure-time product, the work of breathing and the respiratory muscle strength with the disease severity
Description
The pressure-time product of the respiratory muscles, the work of breathing and the respiratory muscle strength will be correlated with disease severity
Time Frame
Day 0
Title
Correlation between the pressure-time product, the work of breathing and the respiratory muscle strength with polysomnography and gas exchange results
Description
The pressure-time product of the respiratory muscles, the work of breathing and the respiratory muscle strength will be correlated with the polysomnography and gas exchange results
Time Frame
Day 0
Title
Esophageal pressure-time products in patients with any treatment and in patients with no treatment
Description
The esophageal pressure-time product will be compared between patients with any treatment and patients receiving no treatment
Time Frame
Day 0
Title
The total work of breathing in patients with any treatment and in patients with no treatment
Description
The total work of breathing (WOBt), which is calculated (in Joules/L) as the area under the pressure-volume curve using the Campbell diagram, be compared between patients with any treatment and patients receiving no traeatment, using the Student t test
Time Frame
Day 0
Title
Measurement of esophageal pressure during a sniff in patients with any treatment and patients with no treatment
Description
The esophageal pressure during a sniff will be compared between patients with any treatment and patients receiving no treatment
Time Frame
Day 0
Title
Measurement of the esophageal pressure-time product before and after pharmacological treatment
Description
The esophageal pressure-time product will be compared before treatment, and 6 months and 1 year after pharmacological treatment initiation
Time Frame
6 months and 1 year after treatment initiation
Title
The total work of breathing before and after pharmacological treatment
Description
The total work of breathing (WOBt), which is calculated (in Joules/L) as the area under the pressure-volume curve using the Campbell diagram, will be compared before treatment, and 6 months and 1 year after pharmacological treatment initiation, using the ANOVA on repeated measures
Time Frame
6 months and 1 year after treatment initiation
Title
Measurement of the esophageal pressure during a sniff before and after pharmacological treatment
Description
The esophageal pressure during a sniff will be compared before treatment, and 6 months and 1 year after pharmacological treatment initiation
Time Frame
6 months and 1 year after treatment initiation
Title
Measurement of transdiaphragmatic pressure during a sniff before and after pharmacological treatment
Description
The transdiaphragmatic pressure measurement during a sniff will be compared before treatment, and 6 months and 1 year after pharmacological treatment initiation
Time Frame
6 months and 1 year after treatment initiation
Title
Adaptation of the respiratory support according to the esophageal pressure-time product values
Description
The esophageal pressure-time product will be measured to guide the respiratory support adaptation
Time Frame
Day 0
Title
Adaptation of the respiratory support according to the total work of breathing values
Description
The total work of breathing (WOBt), which is calculated (in Joules/L) as the area under the pressure-volume curve using the Campbell diagram, will be measured to guide the respiratory support adaptation
Time Frame
Day 0
Title
Measurement of the esophageal pressure-time product in patients with weaning success and in patients with weaning failure
Description
The esophageal pressure-time product will be compared between patients with weaning success and weaning failure
Time Frame
Day 0
Title
Measurement of the total work of breathing in patients with weaning success and in patients with weaning failure
Description
The total work of breathing (WOBt), which is calculated (in Joules/L) as the area under the pressure-volume curve using the Campbell diagram, will be compared between patients with weaning success and weaning failure, using the Student t test
Time Frame
Day 0
Title
Measurement of the esophageal pressure during a sniff in patients with weaning success and in patients with weaning failure
Description
The esophageal pressure during a sniff will be compared between patients with weaning success and weaning failure
Time Frame
Day 0
Title
Correlation between the pressure-time product, the work of breathing and the respiratory muscle strength with the gas exchange during weaning trial
Description
The pressure-time product, the work of breathing and the respiratory muscle strength will be correlated with the gas exchange during a weaning trial
Time Frame
Day 0

10. Eligibility

Sex
All
Minimum Age & Unit of Time
0 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients aged less than 18 years old with primary or secondary impairment of respiratory muscles and followed at Necker Hospital Patients under spontaneous breathing or noninvasive or invasive mechanical ventilation Written informed consent Exclusion Criteria: No social insurance Significant psychomotor retardation Absence of cooperation Significant agitation Hemodynamic instability Acute condition or temporary drug treatments that may interfere with the results of the respiratory muscle explorations
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Brigitte FAUROUX, MD, PhD
Phone
1 71 19 60 92
Ext
+33
Email
brigitte.fauroux@aphp.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Hélène MOREL
Phone
1 71 19 63 46
Ext
+33
Email
helene.morel@aphp.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brigitte FAUROUX, MD, PhD
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Sonia KHIRANI, PhD
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Study Director
Facility Information:
Facility Name
Hôpital Necker-Enfants Malades
City
Paris
ZIP/Postal Code
75015
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Brigitte FAUROUX, MD, PhD
Phone
1 71 19 60 92
Ext
+33
Email
brigitte.fauroux@aphp.fr
First Name & Middle Initial & Last Name & Degree
Lucie GRIFFON, MD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Respiratory Muscles and Work of Breathing in Children

We'll reach out to this number within 24 hrs